title: E4BP4 facilitates glucocorticoid-evoked apoptosis of human leukemic CEM cells via upregulation of Bim.
abstract: BACKGROUND
  Synthetic GCs serve as therapeutic agents for some lymphoid leukemias because of their ability to induce transcriptional changes via the GC receptor (GR) and trigger apoptosis. Upregulation of the BH3-only member of Bcl-2 family proteins, Bim, has been shown to be essential for GC-evoked apoptosis of leukemic lymphoblasts. Using human T cell leukemic sister clones CEM-C7-14 and CEM-C1-15, we have previously shown that the bZIP transcriptional repressor, E4BP4, is preferentially upregulated by GCs in CEM-C7-14 cells that are susceptible to GC-evoked apoptosis, but not in refractory CEM-C1-15 cells. E4BP4 is an evolutionarily conserved member of the PAR family of bZIP transcription factors related to the C. elegans death specification gene ces2.
  
  
  RESULTS
  Mouse E4BP4 was ectopically expressed in CEM-C1-15 cells, resulting in sensitization to GC-evoked apoptosis in correlation with restoration of E4BP4 and Bim upregulation. shRNA mediated modest knockdown of E4BP4 in CEM-C7-14 cells resulted in concomitant reduction in Bim expression, although GC-evoked fold-induction and sensitivity to apoptosis was similar to parental cells.
  
  
  CONCLUSIONS
  Data presented here suggest that GC-mediated upregulation of E4BP4 facilitates Bim upregulation and apoptosis of CEM cells. Since the Bim promoter does not contain any consensus GRE or EBPRE sequences, induction of Bim may be a secondary response.
authors.affiliation: Department of Biology, California State University Northridge, Northridge, CA 91330-8303, USA. rheem.medh@csun.edu.
authors.forename: Jessica A
authors.initials: JA
authors.lastname: Beach
authors.forename: Laura J
authors.initials: LJ
authors.lastname: Nary
authors.forename: Yasuko
authors.initials: Y
authors.lastname: Hirakawa
authors.forename: Eli
authors.initials: E
authors.lastname: Holland
authors.forename: Rebeka
authors.initials: R
authors.lastname: Hovanessian
authors.forename: Rheem D
authors.initials: RD
authors.lastname: Medh